(Q39821574)

14 September 2017

RIG-I activation inhibits ebolavirus replication (English)

1 reference

14 September 2017

10

Thomas G Ksiazek

1 reference

14 September 2017

8

Pierre E Rollin

1 reference

14 September 2017

9

Stuart T Nichol

1 reference

14 September 2017

3

Melissa B Pearce

1 reference

14 September 2017

4

Tara K Sealy

1 reference

14 September 2017

Suryaprakash Sambhara

11

object named as

Suryaprakash Sambhara

1 reference

14 September 2017

Christina F Spiropoulou

1

object named as

Christina F Spiropoulou

1 reference

14 September 2017

Priya Ranjan

2

1 reference

14 September 2017

César G Albariño

5

1 reference

14 September 2017

Shivaprakash Gangappa

6

1 reference

14 September 2017

Takashi Fujita

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

23 July 2009

1 reference

14 September 2017

1 reference

14 September 2017

392

1 reference

14 September 2017

11-15

1 reference

14 September 2017

1

1 reference

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Viral evasion and subversion of pattern-recognition receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

The promises and pitfalls of RNA-interference-based therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

The Ebola virus VP35 protein is a suppressor of RNA silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

5'-Triphosphate RNA is the ligand for RIG-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Essential role of IPS-1 in innate immune responses against RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Development of treatment strategies to combat Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Innate immunity to virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.06.032

10.1016/J.VIROL.2009.06.032

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference